Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604367 · ClinicalTrials.gov registry record
Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 21
- Enrollment target
NCT03604367 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 21 participants.
The verdict
NCT03604367 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Less than 50% of stroke survivors progress to independent community ambulation. Even among the stroke survivors who achieve independent ambulation, significant residual deficits persist in balance and gait speed, with 60% of persons post-stroke reporting limitations in mobility related to walking.Consequently maximizing recovery of locomotor function is the focus of neurorehabilitation efforts worldwide. A recently completed clinical trial from members of this investigative team demonstrated that 6 weeks of treadmill training elicits substantial improvements in over ground walking speed and symmetry in persons following stroke. Consistent with the goals of the South Carolina Stroke Rehabilitation Research Center (SCSRRC) and NIH Brain Initiative, the investigators now plan to investigate the effects treadmill-assisted gait training have on cortical control of bipedal movement in chronic stroke patients. Although previous investigators have assessed neural activity during simulated walking using motor imagery, motor imagery does not simulate the typical sensory feedback associated with active movement. To move the field forward, it is necessary to measure active bipedal movement in the MR-environment in healthy volunteers, before moving forward in stroke patients.
Interventions
- DEVICE GAITRite assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03604367
The ClinicalTrials.gov registry entry for NCT03604367 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GAITRite assessment is the first listed.
NCT03604367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03604367 about?
NCT03604367 is a clinical study titled "Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI". Less than 50% of stroke survivors progress to independent community ambulation. Even among the stroke survivors who achieve independent ambulation, significant residual deficits persist in balance and gait speed, with 60% of persons post-stroke reporting limitations in mobility related to walking.Co...
What is the current status of trial NCT03604367?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-02-01. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03604367?
The interventions under investigation include: GAITRite assessment (DEVICE).
Who is sponsoring clinical trial NCT03604367?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.